患者参与药监的"最佳"方式是什么?
1East Tennessee State University, Johnson City, Tennessee, USA.
The Journal of medicine and philosophy
|October 16, 2024
概括
患者参与药监可以改善药物不良反应报告. 本研究提出了一个评估患者参与策略的框架,确保为更好的药物安全监测提供道德,公正和实际的方法.
科学领域:
- 药物监督和患者参与
- 医学科学中的生物伦理学
- 医疗信息学 医疗信息学
背景情况:
- 怀疑药物不良反应 (ADRs) 的报告不足是药物监督的一个重大挑战.
- 目前的解决方案主要针对医疗保健专业人员,忽视了公众参与的潜力.
- 越来越多的公众参与医学科学需要新的方法来报告ADR.
研究的目的:
- 为患者参与药物监督提出一个评估框架.
- 评估未来关于让患者参与缓解ADR报告不足的建议.
- 为评估现有的患者报告实践提供一个工具.
主要方法:
- 开发一个由三个标准组成的评估框架:生物伦理,社会认识论和务实.
- 标准1:确保患者不会受到不必要的伤害,例如nocebo效应.
- 标准2:优先考虑药物监督目标,在数据处理中不受行业偏见的影响.
- 标准3:考虑实用性约束,如临床医生买入和基础设施.
主要成果:
- 拟议的框架提供了一个结构化的方法来评估患者参与药物监督的倡议.
- 它强调了伦理考虑,数据完整性和实际可行性的重要性.
- 符合这些标准的提案被认为是加强ADR报告的首选方案.
结论:
- 让患者参与药物监测具有改善药物安全的巨大潜力.
- 评估框架为开发和评估以患者为中心的报告策略提供了一个强有力的方法.
- 采用这种框架可以带来更有效和可靠的药监系统.
更多相关视频
06:28E-Patient Counseling Trial E-PACO: Computer Based Education versus Nurse Counseling for Patients to Prepare for Colonoscopy
Published on: August 1, 2019
8.3K
09:33Visualizing Field Data Collection Procedures of Exposure and Biomarker Assessments for the Household Air Pollution Intervention Network Trial in India
Published on: December 23, 2022
2.2K
相关概念视频
Pharmacovigilance
783
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
783
Clinical Trials: Overview
2.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
2.9K
Analysis of Population Pharmacokinetic Data
237
Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
237
Clinical Trials
6.6K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
There are four phases in a clinical trial. A phase one...
6.6K
Drug Regulation
1.3K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.3K
Preclinical Development: Overview
4.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
4.3K
